Business Insights January 2021
February 2021
Previous reports
Business Insights July 2021
FEATURING
EXPERT INSIGHT:
Solving the problem of financing one-time treatments with evidence uncertainty: which types of outcomes-based payment models could work best for novel CAR-T therapies in multiple myeloma? A systematic review of the published literature
COMMENTARY:
Critical need for establishing value that justifies the current rising costs of cell and gene therapy
